InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kodiak Sciences Inc.

KOD Clue Score29
United States Fiscal year ends December CIK 0001468748
$99.87 +5.95% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $99.87 −4.27% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 4 Oct 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2016Operating income−17.2Net income−17.1Fiscal year 2017Operating income−25.5Net income−27.9Fiscal year 2018Operating income−26.4Net income−41.4Fiscal year 2019Operating income−49.2Net income−47.4Fiscal year 2020Operating income−136.0Net income−133.1EPS, diluted−2.91Fiscal year 2021Operating income−267.1Net income−267.0EPS, diluted−5.16Fiscal year 2022Operating income−341.4Net income−333.8EPS, diluted−6.39Fiscal year 2023Operating income−277.3Net income−260.5EPS, diluted−4.97Fiscal year 2024Operating income−186.8Net income−176.2EPS, diluted−3.35Fiscal year 2025Operating income−234.4Net income−230.0EPS, diluted−4.32
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income −17.2 −25.5 −26.4 −49.2 −136.0 −267.1 −341.4 −277.3 −186.8 −234.4
Net income −17.1 −27.9 −41.4 −47.4 −133.1 −267.0 −333.8 −260.5 −176.2 −230.0
Growth
EPS, diluted n/a n/a n/a n/a −2.91 −5.16 −6.39 −4.97 −3.35 −4.32
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−16.0Capital expenditure−0.8Free cash flow−16.8Buybacks−0.0Fiscal year 2017Operating cash flow−17.7Capital expenditure−0.2Free cash flow−17.9Buybacks0.0Fiscal year 2018Operating cash flow−29.0Capital expenditure−0.1Free cash flow−29.1Buybacks0.0Fiscal year 2019Operating cash flow−39.1Capital expenditure−0.4Free cash flow−39.6Fiscal year 2020Operating cash flow−83.4Capital expenditure−3.8Free cash flow−87.2Fiscal year 2021Operating cash flow−182.3Capital expenditure−17.0Free cash flow−199.3Fiscal year 2022Operating cash flow−206.5Capital expenditure−37.0Free cash flow−243.5Fiscal year 2023Operating cash flow−154.2Capital expenditure−41.4Free cash flow−195.5Fiscal year 2024Operating cash flow−117.3Capital expenditure−0.4Free cash flow−117.7Fiscal year 2025Operating cash flow−136.0Capital expenditure−0.5Free cash flow−136.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −16.0 −17.7 −29.0 −39.1 −83.4 −182.3 −206.5 −154.2 −117.3 −136.0
Capital expenditure −0.8 −0.2 −0.1 −0.4 −3.8 −17.0 −37.0 −41.4 −0.4 −0.5
Free cash flow −16.8 −17.9 −29.1 −39.6 −87.2 −199.3 −243.5 −195.5 −117.7 −136.5
Growth
Buybacks −0.0 0.0 0.0 n/a n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash9.6Shareholders’ equity−41.1Fiscal year 2017Cash1.4Shareholders’ equity−68.7Fiscal year 2018Cash88.3Shareholders’ equity86.8Fiscal year 2019Cash211.8Shareholders’ equity345.4Fiscal year 2020Cash944.4Shareholders’ equity860.8Fiscal year 2021Cash731.5Shareholders’ equity663.3Fiscal year 2022Cash190.4Shareholders’ equity436.2Fiscal year 2023Cash285.5Shareholders’ equity265.8Fiscal year 2024Cash168.1Shareholders’ equity150.3Fiscal year 2025Cash209.9Shareholders’ equity157.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 9.6 1.4 88.3 211.8 944.4 731.5 190.4 285.5 168.1 209.9
Shareholders’ equity −41.1 −68.7 86.8 345.4 860.8 663.3 436.2 265.8 150.3 157.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
14.1 22.0 18.8 37.5 107.4 217.3 267.6 206.3 126.1 182.4
3.1 3.5 7.6 11.7 28.6 49.7 73.8 71.0 60.8 52.0
−17.2 −25.5 −26.4 −49.2 −136.0 −267.1 −341.4 −277.3 −186.8 −234.4
Growth
−17.1 −27.9 −41.4 −47.4 −133.1 −266.9 −333.8 −260.4 −176.2 −229.9
n/a n/a n/a n/a 0.0 0.1 0.0 0.0 0.0 0.1
−17.1 −27.9 −41.4 −47.4 −133.1 −267.0 −333.8 −260.5 −176.2 −230.0
Growth
Per share
n/a n/a n/a n/a −2.91 −5.16 −6.39 −4.97 −3.35 −4.32
n/a n/a n/a n/a −2.91 −5.16 −6.39 −4.97 −3.35 −4.32
Growth
n/a n/a n/a n/a 45.7 51.8 52.2 52.4 52.6 53.2
n/a n/a n/a n/a 45.7 51.8 52.2 52.4 52.6 53.2
Growth +13.2% +0.9% +0.3% +0.3% +1.2%

Five years in brief

Worked out from the figures above, not from a press release
  • The diluted share count rose 16.3% in five years, which is dilution.
  • A net loss in 10 of 10 years on file.